Канал: Bloodline

Mobilization for Myeloma and Lymphoma

Mobilization for Myeloma and Lymphoma

Optimal Mobilization Strategies

Optimal Mobilization Strategies

Breakthrough Therapies for Acute GVHD

Breakthrough Therapies for Acute GVHD

The Role of the Microbiome in GvHD

The Role of the Microbiome in GvHD

Clinical Outcomes of New and Emerging Targeted Conditioning Regimens

Clinical Outcomes of New and Emerging Targeted Conditioning Regimens

Updates on Hematologic Malignancies New Targeted Conditioning Regimens: Welcome and Introduction

Updates on Hematologic Malignancies New Targeted Conditioning Regimens: Welcome and Introduction

CD 19 CAR T Cells in Leukemia

CD 19 CAR T Cells in Leukemia

CAR T-Cell Therapy for Hematological Malignancies Other Than CD19

CAR T-Cell Therapy for Hematological Malignancies Other Than CD19

Antigen Presentation in Acute GVHD

Antigen Presentation in Acute GVHD

Acute GVHD: Biomarkers and Biology

Acute GVHD: Biomarkers and Biology

Novel Conditioning Regimens for Adults with ALL

Novel Conditioning Regimens for Adults with ALL

Dose Intensity in MDS and AML: Does It Matter?

Dose Intensity in MDS and AML: Does It Matter?